Assessment of nutritional status in patients with primary lung cancer
##plugins.themes.academic_pro.article.main##
Abstract
Background: Lung cancer is the leading cause of cancer-related mortality worldwide. Malnutrition is a common problem among patients with cancer, affecting up to 85% of patients with certain cancers and represents a risk factor for poor prognosis.
aim: evaluate nutritional status in patients with lung cancer before and during treatment using nutritional risk index.
methods: it’s a prospective study conducted in pneumology IV department in Abderahman Mami hospital, from January to May 2011. 30 male patients with a lung cancer were included. Nutritional status was assessed before and during treatment based on anthropometric measures, biological markers and nutritional risk index (NRI).
results: Mean age of patients was 58 ± 12 years, ranging from 19 to 82 years. 29 patients had non small cell lung cancer and one patient had small cell cancer. Malnutrition was noted in 14 patients (47%) before treatment according to the NRI. It was noted in 23 patients (77%) after three cycles of chemotherapy with severe malnutrition in 8 patients. Relationship between body mass index (BMI) and the NRI was linear, but NRI tends to evaluate more objectively risk of malnutrition in patients with lung cancer.
Conclusion: Nutritional assessment in patient with lung cancer should be performed systematically, early and repeatedly. Several markers can be used such as BMI and NRI. Nutritional support will reduce morbidity and improve quality of life in patients with lung cancer.
aim: evaluate nutritional status in patients with lung cancer before and during treatment using nutritional risk index.
methods: it’s a prospective study conducted in pneumology IV department in Abderahman Mami hospital, from January to May 2011. 30 male patients with a lung cancer were included. Nutritional status was assessed before and during treatment based on anthropometric measures, biological markers and nutritional risk index (NRI).
results: Mean age of patients was 58 ± 12 years, ranging from 19 to 82 years. 29 patients had non small cell lung cancer and one patient had small cell cancer. Malnutrition was noted in 14 patients (47%) before treatment according to the NRI. It was noted in 23 patients (77%) after three cycles of chemotherapy with severe malnutrition in 8 patients. Relationship between body mass index (BMI) and the NRI was linear, but NRI tends to evaluate more objectively risk of malnutrition in patients with lung cancer.
Conclusion: Nutritional assessment in patient with lung cancer should be performed systematically, early and repeatedly. Several markers can be used such as BMI and NRI. Nutritional support will reduce morbidity and improve quality of life in patients with lung cancer.
Keywords:
Lung cancer, malnutrition, treatment, Nutritional risk index##plugins.themes.academic_pro.article.details##
References
- Jemal A, Thun MJ, Ries LG, et al. Annual Report to the Nation on the Status of Cancer, 1975-2005, Featuring Trends in Lung Cancer, Tobacco Use and Tobacco Control. J Natl Cancer Inst 2008; 100: 1672-94.
- Duguet A, Bachmann P, Lallemand Y, Blanc-Vincent M. Bonnes pratiques diététiques en cancérologie : Dénutrition et évaluation nutritionnelle. Bull cancer 1999; 86: 997-1016.
- Tartari RF, Ulbrich-Kulczynski JM, Filho AF. Measurement of mid-arm muscle circumference and prognosis in stage IV nonsmall cell lung cancer patients. Oncol Lett 2013; 5:1063-7.
- Argilés J.M. Cancer-associated malnutrition. Eur J Oncol Nurs 2005; 9 Suppl 2: S39-50. [5] Ramos Chaves M, Boléo-Tomé C, Monteiro-Grillo I, Camilo M, Ravasco P. The Diversity of Nutritional Status in Cancer: New Insights. Oncologist 2010;15:523-30
- Bouillanne O, Morineau G, Dupont C et al. Geriatric Nutritional Risk Index: a new index for evaluating at-risk elderly medical patients. Am J Clin Nutr. 2005; 82:777-83.
- Scott HR, McMillan DC, Brown DJ, Forrest LM, McArdle CS, Milroy R. A prospective study of the impact of weight loss and the systemic inflammatory response on quality of life in patients with inoperable non-small cell lung cancer. Lung Cancer 2003; 40:295-299.
- Ovesen L, Hannibal J, Mortensen EL . The interrelationship of weight loss, dietary intake,
- and quality of life in ambulatory patients with cancer of the lung, breast, and ovary. Nutr Cancer 1993;19 :159-167.
- L. Alouane, B. Abdelmoncef, R. Khaled. Apport de l'impédancemétrie dans le dépistage de la dénutrition chez un groupe de patients tunisiens atteints de cancer. Bull cancer 2006; 93. 10.
- Ryu SW, Kim IH. Comparison of different nutritional assessments in detecting malnutrition among gastric cancer patients. World J Gastroenterol 2010; 16:3310-7.
- Zhang L, Su Y, Wang C et al. Assessing the nutritional status of elderly Chinese lung cancer patients using the Mini-Nutritional Assessment (MNA(®)) tool. Clin Interv Aging 2013; 8:287-91.
- Boukhettala N, Leblond J, Claeyssens S et al. Methotrexate induces intestinal mucositis and alters gut protein metabolism independently of reduced food intake. Am J Physiol Endocrinol Metab 2009; 296: E182-90.
- MarÃn Caro MM, Gómez Candela C, Castillo Rabaneda R et al. Nutritional risk evaluation and establishment of nutritional support in oncology patients according to the protocol of the Spanish Nutrition and Cancer Group. Nutr Hosp 2008; 23:458-68.
- Antoun S, Merad M, Raynard B, Ruffie P. Evaluating the nutritional status of a lung cancer patient is an important element in patient management. Rev Pneumol Clin 2008; 64:92-8.
- Dayot F, Bataillard A, Keré C et al. Standards, options and recommendations: Good clinical practice in the dietetic management of cancer patients: hospital catering. Bull Cancer 2000; 88:1007-18.
- Demoor-Goldschmidt C, Raynard B. How can we integrate nutritional support in medical oncology? Bull Cancer 2009; 96: 665-75.
- Koom WS, Ahn SD, Song SY et al. Nutritional status of patients treated with radiotherapy as determined by subjective global assessment. Radiat Oncol J 2012; 30: 132-9.
- Ghisolfi-Marque A. Denutrition in the elderly patient with urologic cancer. Prog Urol 2009; 19 Suppl 3: S106-9.